Letter by Alkhalil Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)".
作者信息
Alkhalil Mohammad
机构信息
Acute Vascular Imaging Centre, Radcliffe Department of Medicine, University of Oxford, UK.
出版信息
Circulation. 2018 Jul 10;138(2):220-221. doi: 10.1161/CIRCULATIONAHA.117.033207.
Abstract
摘要
Zotero 插件